Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph early_phase_1
1
17%
Ph not_applicable
2
33%
Ph phase_3
1
17%
Ph phase_4
2
33%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A2 (33.3%)

Trials by Status

not_yet_recruiting117%
unknown233%
completed350%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6